Review



injection mix  (World Precision Instruments)


Bioz Verified Symbol World Precision Instruments is a verified supplier
Bioz Manufacturer Symbol World Precision Instruments manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    World Precision Instruments injection mix
    Injection Mix, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 96/100, based on 1336 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/injection mix/product/World Precision Instruments
    Average 96 stars, based on 1336 article reviews
    injection mix - by Bioz Stars, 2026-04
    96/100 stars

    Images



    Similar Products

    96
    Thermo Fisher injection mix
    Injection Mix, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/injection mix/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    injection mix - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    96
    World Precision Instruments injection mix
    Injection Mix, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/injection mix/product/World Precision Instruments
    Average 96 stars, based on 1 article reviews
    injection mix - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    95
    World Precision Instruments dna mrna injection mix
    Dna Mrna Injection Mix, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dna mrna injection mix/product/World Precision Instruments
    Average 95 stars, based on 1 article reviews
    dna mrna injection mix - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    93
    Addgene inc bopto bmp combined in injection mix bopto bmpr1aa addgene 207614
    A,B,C) Schematic of constructs used here to activate FGF (A), <t>BMP</t> (B), and Nodal (C) signaling. Myr = myristoylation motif, GS = glycine/serine linker, LOV = light oxygen voltage-sensing domain, HA = hemagglutinin tag, FLAG = FLAG epitope. The single-transcript <t>bOpto-2A-Nodal</t> construct (C) follows the same design as -FGF and -BMP, except the type I (Acvr1ba) and type II (Acvr2ba) components are connected via a 2A peptide sequence (gray). A’,B’,C’) Optogenetic strategy to activate FGF (A’), BMP (B’), and Nodal (C’) signaling. Blue light-dimerizing LOV domains are fused to myristoylated receptor kinase domains. Blue light exposure should lead to receptor kinase interactions, signaling effector phosphorylation, and activation of target genes.
    Bopto Bmp Combined In Injection Mix Bopto Bmpr1aa Addgene 207614, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bopto bmp combined in injection mix bopto bmpr1aa addgene 207614/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    bopto bmp combined in injection mix bopto bmpr1aa addgene 207614 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    90
    Tonghua Dongbao mixed protamine zinc recombinant human insulin lispro injection
    Mean (±SD) plasma concentration–time curves (profile of changes in the blood concentration over time) (A) and semi-logarithmic curves (B) of the test and reference products of insulin <t>lispro</t> 25.
    Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection, supplied by Tonghua Dongbao, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mixed protamine zinc recombinant human insulin lispro injection/product/Tonghua Dongbao
    Average 90 stars, based on 1 article reviews
    mixed protamine zinc recombinant human insulin lispro injection - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Eli Lilly mixed protamine zinc recombinant human insulin lispro injection humalog ® 25
    Mean (±SD) plasma concentration–time curves (profile of changes in the blood concentration over time) (A) and semi-logarithmic curves (B) of the test and reference products of insulin <t>lispro</t> 25.
    Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection Humalog ® 25, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mixed protamine zinc recombinant human insulin lispro injection humalog ® 25/product/Eli Lilly
    Average 90 stars, based on 1 article reviews
    mixed protamine zinc recombinant human insulin lispro injection humalog ® 25 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    95
    Addgene inc injection mix comprised peft
    Mean (±SD) plasma concentration–time curves (profile of changes in the blood concentration over time) (A) and semi-logarithmic curves (B) of the test and reference products of insulin <t>lispro</t> 25.
    Injection Mix Comprised Peft, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/injection mix comprised peft/product/Addgene inc
    Average 95 stars, based on 1 article reviews
    injection mix comprised peft - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    90
    Novo Nordisk novolin ® 30r (mixed protamine human insulin injection (30r
    UV-Vis absorption response curves of AuNPs/GO (prepared with reducing agent 1.8 mL) to pure <t>insulin</t> solutions at different concentrations (18–30 μM).
    Novolin ® 30r (Mixed Protamine Human Insulin Injection (30r, supplied by Novo Nordisk, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/novolin ® 30r (mixed protamine human insulin injection (30r/product/Novo Nordisk
    Average 90 stars, based on 1 article reviews
    novolin ® 30r (mixed protamine human insulin injection (30r - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    A,B,C) Schematic of constructs used here to activate FGF (A), BMP (B), and Nodal (C) signaling. Myr = myristoylation motif, GS = glycine/serine linker, LOV = light oxygen voltage-sensing domain, HA = hemagglutinin tag, FLAG = FLAG epitope. The single-transcript bOpto-2A-Nodal construct (C) follows the same design as -FGF and -BMP, except the type I (Acvr1ba) and type II (Acvr2ba) components are connected via a 2A peptide sequence (gray). A’,B’,C’) Optogenetic strategy to activate FGF (A’), BMP (B’), and Nodal (C’) signaling. Blue light-dimerizing LOV domains are fused to myristoylated receptor kinase domains. Blue light exposure should lead to receptor kinase interactions, signaling effector phosphorylation, and activation of target genes.

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: A,B,C) Schematic of constructs used here to activate FGF (A), BMP (B), and Nodal (C) signaling. Myr = myristoylation motif, GS = glycine/serine linker, LOV = light oxygen voltage-sensing domain, HA = hemagglutinin tag, FLAG = FLAG epitope. The single-transcript bOpto-2A-Nodal construct (C) follows the same design as -FGF and -BMP, except the type I (Acvr1ba) and type II (Acvr2ba) components are connected via a 2A peptide sequence (gray). A’,B’,C’) Optogenetic strategy to activate FGF (A’), BMP (B’), and Nodal (C’) signaling. Blue light-dimerizing LOV domains are fused to myristoylated receptor kinase domains. Blue light exposure should lead to receptor kinase interactions, signaling effector phosphorylation, and activation of target genes.

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Construct, FLAG-tag, Sequencing, Phospho-proteomics, Activation Assay

    Measured spectra for A) the 455 nm light used in uniform blue light exposure experiments (all figures except ), B) the 495+ nm used in and Supp. Figs. 2, 3, 4, & 12, and C) the 600 nm light source used to avoid inadvertent signaling activation during handling of embryos expressing bOpto constructs.

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: Measured spectra for A) the 455 nm light used in uniform blue light exposure experiments (all figures except ), B) the 495+ nm used in and Supp. Figs. 2, 3, 4, & 12, and C) the 600 nm light source used to avoid inadvertent signaling activation during handling of embryos expressing bOpto constructs.

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Activation Assay, Expressing, Construct

    A) Uninjected (-) embryos and embryos injected (+) at the one-cell stage with the indicated mRNA were exposed to dark, 495+ nm light (18.51 W/m 2 ), or 455 nm light (50 W/m 2 ) starting ∼2 hours post-fertilization (hpf). Phenotypes were scored at 1 day post-fertilization (dpf) (N = 3; ; Mean +/- SD). B,C,D) Uninjected embryos and embryos injected with the indicated bOpto + GFP mRNA were exposed to dark, 495+ nm light, or 455 nm light starting at early gastrulation (50% epiboly - shield) for 30 min. HCR-IF was used to detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). Scale bar is 200 µm. B’,C’,D’) Quantification of experiments shown in B,C,D. Linear-mixed model-predicted least squared means of GFP-normalized phosphorylated effector signal +/- SEM. D’ shows nuclear signal only. (N = 3, * indicates p < 0.05; & ).

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: A) Uninjected (-) embryos and embryos injected (+) at the one-cell stage with the indicated mRNA were exposed to dark, 495+ nm light (18.51 W/m 2 ), or 455 nm light (50 W/m 2 ) starting ∼2 hours post-fertilization (hpf). Phenotypes were scored at 1 day post-fertilization (dpf) (N = 3; ; Mean +/- SD). B,C,D) Uninjected embryos and embryos injected with the indicated bOpto + GFP mRNA were exposed to dark, 495+ nm light, or 455 nm light starting at early gastrulation (50% epiboly - shield) for 30 min. HCR-IF was used to detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). Scale bar is 200 µm. B’,C’,D’) Quantification of experiments shown in B,C,D. Linear-mixed model-predicted least squared means of GFP-normalized phosphorylated effector signal +/- SEM. D’ shows nuclear signal only. (N = 3, * indicates p < 0.05; & ).

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection

    A-C”) Uninjected embryos (-) and embryos injected (+) at the one-cell stage with the bOp- to-FGF (A-A”), bOpto-BMP (B-B”), or bOpto-2A-Nodal (C-C”) mRNA were exposed to dark, 495+ nm light (18.51 W/m 2 ), or 455 nm light (50 W/m 2 ) starting 1.5-2 hours post-fertilization. Phenotypes were scored at 1 day post-fertilization. Individual repeats are shown. Numbers indicate the total number of embryos scored in each condition for that experiment. shows the combined data from these three repeats. Phenotype legend images shown here are the same images shown in .

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: A-C”) Uninjected embryos (-) and embryos injected (+) at the one-cell stage with the bOp- to-FGF (A-A”), bOpto-BMP (B-B”), or bOpto-2A-Nodal (C-C”) mRNA were exposed to dark, 495+ nm light (18.51 W/m 2 ), or 455 nm light (50 W/m 2 ) starting 1.5-2 hours post-fertilization. Phenotypes were scored at 1 day post-fertilization. Individual repeats are shown. Numbers indicate the total number of embryos scored in each condition for that experiment. shows the combined data from these three repeats. Phenotype legend images shown here are the same images shown in .

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection

    Uninjected embryos (-) and embryos injected (+) at the one-cell stage with mRNA encoding bOpto-FGF (A) , bOp- to-BMP (B) , or bOpto-2A-Nodal (C) were exposed to 455 nm light (50 W/m 2 , bottom rows) or dark (top rows) for 2 hours starting before gastrulation (dome - 30% epiboly). Multiplexed HCR-FISH was used to detect expression of the indicated pathway target genes. (N = 3; Scale bar is 200 µm).

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: Uninjected embryos (-) and embryos injected (+) at the one-cell stage with mRNA encoding bOpto-FGF (A) , bOp- to-BMP (B) , or bOpto-2A-Nodal (C) were exposed to 455 nm light (50 W/m 2 , bottom rows) or dark (top rows) for 2 hours starting before gastrulation (dome - 30% epiboly). Multiplexed HCR-FISH was used to detect expression of the indicated pathway target genes. (N = 3; Scale bar is 200 µm).

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection, Expressing

    Uninjected embryos (-) and embryos injected (+) at the one-cell stage with mRNA encoding bOpto-FGF (A) , bOpto-BMP (B) , or bOpto-2A-Nodal (C) were exposed to dark (left panel) or 455 nm light (50 W/m 2 , right panel) for 30 minutes starting at gastrulation (50% epiboly - shield). Triple IF was used to simultaneously detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). (N = 3; ; Scale bar is 200 µm).

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: Uninjected embryos (-) and embryos injected (+) at the one-cell stage with mRNA encoding bOpto-FGF (A) , bOpto-BMP (B) , or bOpto-2A-Nodal (C) were exposed to dark (left panel) or 455 nm light (50 W/m 2 , right panel) for 30 minutes starting at gastrulation (50% epiboly - shield). Triple IF was used to simultaneously detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). (N = 3; ; Scale bar is 200 µm).

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection

    A-E) Embryos injected at the one-cell stage with mRNA encoding bOpto-2A-Nodal exposed to dark (left panel) or 455 nm light (50 W/m 2 , right panel) starting at early gastrulation (50% epiboly - shield stage) for 30 min. Triple IF staining was used to simultaneously detect activated signaling effectors (pSmad1, ppERK, and pSmad2 reflecting BMP, FGF, and Nodal signaling, respectively). Only ppERK and pSmad2 shown here. Three bOpto-2A-Nodal-expressing embryos per condition from five experimental repeats are shown. (Scale bar is 200 µm).

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: A-E) Embryos injected at the one-cell stage with mRNA encoding bOpto-2A-Nodal exposed to dark (left panel) or 455 nm light (50 W/m 2 , right panel) starting at early gastrulation (50% epiboly - shield stage) for 30 min. Triple IF staining was used to simultaneously detect activated signaling effectors (pSmad1, ppERK, and pSmad2 reflecting BMP, FGF, and Nodal signaling, respectively). Only ppERK and pSmad2 shown here. Three bOpto-2A-Nodal-expressing embryos per condition from five experimental repeats are shown. (Scale bar is 200 µm).

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection, Staining, Expressing

    Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF , bOpto-BMP , or bOp- to-2A-Nodal . A,B,C) Starting at early gastrulation (50% epiboly - shield), embryos were either kept in the dark (top row) or exposed to 455 nm light (50 W/m 2 ) light for 30 min (bottom row) and fixed during and after exposure. HCR-IF was used to detect activated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). (N = 3; Scale bar is 200 µm). A’,B’,C’) Quantification of experiments shown in A-C. Signal was GFP-normalized and subtracted against dark time-matched controls (N = 3; each N indicated by matched shape; & ; Mean +/- SD; * indicates p < 0.05 when compared to time = 0 min). A’’- C’’, A’’’-C’’’) A three-parameter logistic regression was fit to the 0-30 min data (A’’-C’’) or the >= 30 min data (A’’’-C’’’). (N = 3; Mean +/- SD; Supplementary Materials; solid line represents predicted curve fit

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF , bOpto-BMP , or bOp- to-2A-Nodal . A,B,C) Starting at early gastrulation (50% epiboly - shield), embryos were either kept in the dark (top row) or exposed to 455 nm light (50 W/m 2 ) light for 30 min (bottom row) and fixed during and after exposure. HCR-IF was used to detect activated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). (N = 3; Scale bar is 200 µm). A’,B’,C’) Quantification of experiments shown in A-C. Signal was GFP-normalized and subtracted against dark time-matched controls (N = 3; each N indicated by matched shape; & ; Mean +/- SD; * indicates p < 0.05 when compared to time = 0 min). A’’- C’’, A’’’-C’’’) A three-parameter logistic regression was fit to the 0-30 min data (A’’-C’’) or the >= 30 min data (A’’’-C’’’). (N = 3; Mean +/- SD; Supplementary Materials; solid line represents predicted curve fit

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection

    A-C) Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOp- to-FGF (A), bOpto-BMP (B), or bOpto-2A-Nodal (C). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) for 30 min and fixed at different time points during and after exposure. HCR-IF staining used to detect activated signaling effectors is shown in (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). HCR-IF signal was normalized voxel-wise based on co-injected GFP intensity shown here (see Supp. Fig. 7). GFP images correspond to representative IF images shown in . (Scale bar is 200 µm).

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: A-C) Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOp- to-FGF (A), bOpto-BMP (B), or bOpto-2A-Nodal (C). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) for 30 min and fixed at different time points during and after exposure. HCR-IF staining used to detect activated signaling effectors is shown in (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). HCR-IF signal was normalized voxel-wise based on co-injected GFP intensity shown here (see Supp. Fig. 7). GFP images correspond to representative IF images shown in . (Scale bar is 200 µm).

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection, Staining

    Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (A,A’), bOpto-BMP (B,B’), or bOpto-2A-Nodal (C,C’). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) for 30 min and fixed during and after exposure. Three full repeats were performed across 3-5 trials. HCR-IF staining used to detect phosphorylated signaling effectors is shown in (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). A,B,C) Raw phosphorylated signaling effector intensity was measured in each DAPI-positive nuclear pixel. Each dot represents the median nuclear pixel intensity in one embryo. Black lines represent the mean nuclear intensity of all embryos in the indicated condition. A’,B’) Phosphorylated siganling effector intensity in each GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized pixel signal in one embryo. Black lines represent the mean GFP-normalized signal of all embryos in the indicated condition. C’) pSmad2 intensity in each DAPI + GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized nuclear pixel signal in one embryo. Black lines represent the mean GFP-normalized nuclear signal of all embryos in the indicated condition.

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (A,A’), bOpto-BMP (B,B’), or bOpto-2A-Nodal (C,C’). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) for 30 min and fixed during and after exposure. Three full repeats were performed across 3-5 trials. HCR-IF staining used to detect phosphorylated signaling effectors is shown in (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). A,B,C) Raw phosphorylated signaling effector intensity was measured in each DAPI-positive nuclear pixel. Each dot represents the median nuclear pixel intensity in one embryo. Black lines represent the mean nuclear intensity of all embryos in the indicated condition. A’,B’) Phosphorylated siganling effector intensity in each GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized pixel signal in one embryo. Black lines represent the mean GFP-normalized signal of all embryos in the indicated condition. C’) pSmad2 intensity in each DAPI + GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized nuclear pixel signal in one embryo. Black lines represent the mean GFP-normalized nuclear signal of all embryos in the indicated condition.

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection, Staining

    A) Table of irradiance and corresponding light dosage values used in B-D’. B,C,D) Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (B), bOpto-BMP (C), or bOpto-2A-Nodal (D). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light at the indicated irradiance for 5 min (bOp- to-FGF, B) or 25 min (bOpto-BMP and -2A-Nodal, C and D). HCR-IF was used to detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively; Scale bar is 200 µm). B’,C’,D’) Quantification of experiments in B-D. Signal was GFP-normalized and subtracted against dark controls. A three-parameter logistic regression was fit to the data. (N = 2-3; each N indicated by matched shape; Mean +/- SD; & ; solid line represents predicted curve fit +/- 95% CI; D’ shows nuclear signal only). Tables indicate goodness of fit (R 2 ), the predicted irradiance (with 95% CI) at which 20 (I 20 ), 50 (I 50 ), and 90% (I 90 ) of the curve’s upper asymptote is reached (Supplementary Materials).

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: A) Table of irradiance and corresponding light dosage values used in B-D’. B,C,D) Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (B), bOpto-BMP (C), or bOpto-2A-Nodal (D). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light at the indicated irradiance for 5 min (bOp- to-FGF, B) or 25 min (bOpto-BMP and -2A-Nodal, C and D). HCR-IF was used to detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively; Scale bar is 200 µm). B’,C’,D’) Quantification of experiments in B-D. Signal was GFP-normalized and subtracted against dark controls. A three-parameter logistic regression was fit to the data. (N = 2-3; each N indicated by matched shape; Mean +/- SD; & ; solid line represents predicted curve fit +/- 95% CI; D’ shows nuclear signal only). Tables indicate goodness of fit (R 2 ), the predicted irradiance (with 95% CI) at which 20 (I 20 ), 50 (I 50 ), and 90% (I 90 ) of the curve’s upper asymptote is reached (Supplementary Materials).

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection

    A-C) Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (A), bOpto-BMP (B), or bOp- to-2A-Nodal (C). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) at the indicated irradiances for 5 min (bOp- to-FGF) or 25 min (bOpto-BMP and -2A-Nodal). HCR-IF staining used to detect phosphorylated signaling effectors is shown in (ppERK, pSmad1, and pSmad2 to reflect FGF, BMP, and Nodal signaling, respectively). HCR-IF signal was normalized based on co-injected GFP intensity shown here; GFP images correspond to representative images shown in . (Scale bar is 200 µm).

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: A-C) Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (A), bOpto-BMP (B), or bOp- to-2A-Nodal (C). Starting at early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) at the indicated irradiances for 5 min (bOp- to-FGF) or 25 min (bOpto-BMP and -2A-Nodal). HCR-IF staining used to detect phosphorylated signaling effectors is shown in (ppERK, pSmad1, and pSmad2 to reflect FGF, BMP, and Nodal signaling, respectively). HCR-IF signal was normalized based on co-injected GFP intensity shown here; GFP images correspond to representative images shown in . (Scale bar is 200 µm).

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection, Staining

    Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (A,A’), bOpto-BMP (B,B’), or bOpto-2A-Nodal (C,C’). At early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) at the indicated irradiance for 5 min (bOpto-FGF) or 25 min (bOpto-BMP and -2A-Nodal). HCR-IF was used to detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). A,B,C) Raw phosphorylated signaling effector intensity was measured in each DAPI-positive nuclear pixel. Each dot represents the median nuclear pixel intensity in one embryo. Black lines represent the mean nuclear intensity of all embryos in the indicated condition. A’,B’) Phosphorylated siganling effector intensity in each GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized pixel signal in one embryo. Black lines represent the mean GFP-normalized signal of all embryos in the indicated condition. C’) pSmad2 intensity in each DAPI + GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized nuclear pixel signal in one embryo. Black lines represent the mean GFP-normalized nuclear signal of all embryos in the indicated condition.

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding GFP and either bOpto-FGF (A,A’), bOpto-BMP (B,B’), or bOpto-2A-Nodal (C,C’). At early gastrulation (50% epiboly - shield), embryos were exposed to 455 nm light (50 W/m 2 ) at the indicated irradiance for 5 min (bOpto-FGF) or 25 min (bOpto-BMP and -2A-Nodal). HCR-IF was used to detect phosphorylated signaling effectors (ppERK, pSmad1, and pSmad2 reflect FGF, BMP, and Nodal signaling, respectively). A,B,C) Raw phosphorylated signaling effector intensity was measured in each DAPI-positive nuclear pixel. Each dot represents the median nuclear pixel intensity in one embryo. Black lines represent the mean nuclear intensity of all embryos in the indicated condition. A’,B’) Phosphorylated siganling effector intensity in each GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized pixel signal in one embryo. Black lines represent the mean GFP-normalized signal of all embryos in the indicated condition. C’) pSmad2 intensity in each DAPI + GFP-positive pixel was divided by the corresponding GFP intensity. Each dot represents the median GFP-normalized nuclear pixel signal in one embryo. Black lines represent the mean GFP-normalized nuclear signal of all embryos in the indicated condition.

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection

    Embryos were injected at the one-cell stage with mRNA encoding the green-to-red photoconvertible fluorescent protein nls-Kaede and bOpto-FGF . At early gastrulation (shield) embryos were either kept in the dark (A) or illuminated locally with 405 and 445 nm confocal lasers (B,B’) . HCR-IF was used to detect ppERK. Dotted white line in B’ outlines photoconverted Kaede in embryo shown in B. ( ; Scale bar is 200 µm).

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding the green-to-red photoconvertible fluorescent protein nls-Kaede and bOpto-FGF . At early gastrulation (shield) embryos were either kept in the dark (A) or illuminated locally with 405 and 445 nm confocal lasers (B,B’) . HCR-IF was used to detect ppERK. Dotted white line in B’ outlines photoconverted Kaede in embryo shown in B. ( ; Scale bar is 200 µm).

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection

    Embryos were injected at the one-cell stage with mRNA encoding the green-to-red photoconvertible fluorescent proteins nls-Kaede and bOpto-FGF . At early gastrulation embryos were either kept in the dark ( A-C, J-L, S-U ) or illuminated locally with 405 and 445 nm confocal lasers. HCR-IF was used to detect ppERK. Two representative exposed embryos from three repeats shown ( D-I’, M-R’, V-AA’ , respectively). Dotted white lines outline photoconverted Kaede from images to the left. A-F’ are shown in . (Scale bar is 200 µm).

    Journal: bioRxiv

    Article Title: An optogenetic toolkit for robust activation of FGF, BMP, & Nodal signaling in zebrafish

    doi: 10.1101/2025.04.17.649426

    Figure Lengend Snippet: Embryos were injected at the one-cell stage with mRNA encoding the green-to-red photoconvertible fluorescent proteins nls-Kaede and bOpto-FGF . At early gastrulation embryos were either kept in the dark ( A-C, J-L, S-U ) or illuminated locally with 405 and 445 nm confocal lasers. HCR-IF was used to detect ppERK. Two representative exposed embryos from three repeats shown ( D-I’, M-R’, V-AA’ , respectively). Dotted white lines outline photoconverted Kaede from images to the left. A-F’ are shown in . (Scale bar is 200 µm).

    Article Snippet: The mRNA amounts injected for each optogenetic tool are listed below: bOpto-FGF (Addgene #232639): 3.5 pg bOpto-BMP (combined in injection mix) bOpto-Bmpr1aa (Addgene # 207614): 23.4 pg bOpto-Acvr1l (Addgene # 207615): 23.4 pg bOpto-Bmpr2a (Addgene # 207616): 40.2 pg

    Techniques: Injection

    Mean (±SD) plasma concentration–time curves (profile of changes in the blood concentration over time) (A) and semi-logarithmic curves (B) of the test and reference products of insulin lispro 25.

    Journal: Frontiers in Pharmacology

    Article Title: Pharmacokinetics and pharmacodynamics of insulin lispro 25 versus the original preparation (Humalog ® 25) in Chinese healthy male volunteers

    doi: 10.3389/fphar.2025.1533548

    Figure Lengend Snippet: Mean (±SD) plasma concentration–time curves (profile of changes in the blood concentration over time) (A) and semi-logarithmic curves (B) of the test and reference products of insulin lispro 25.

    Article Snippet: The test (T) formulation was a mixed protamine zinc recombinant human insulin lispro injection (3 mL: 300U), provided by Tonghua Dongbao Pharmaceutical Co., Ltd. (lot number: 2L12020100052).

    Techniques: Clinical Proteomics, Concentration Assay

    Mean (±SD) glucose infusion rate versus time of insulin lispro 25 (both test and reference products).

    Journal: Frontiers in Pharmacology

    Article Title: Pharmacokinetics and pharmacodynamics of insulin lispro 25 versus the original preparation (Humalog ® 25) in Chinese healthy male volunteers

    doi: 10.3389/fphar.2025.1533548

    Figure Lengend Snippet: Mean (±SD) glucose infusion rate versus time of insulin lispro 25 (both test and reference products).

    Article Snippet: The test (T) formulation was a mixed protamine zinc recombinant human insulin lispro injection (3 mL: 300U), provided by Tonghua Dongbao Pharmaceutical Co., Ltd. (lot number: 2L12020100052).

    Techniques:

    Bio-equivalence between the insulin  lispro  test and reference products.

    Journal: Frontiers in Pharmacology

    Article Title: Pharmacokinetics and pharmacodynamics of insulin lispro 25 versus the original preparation (Humalog ® 25) in Chinese healthy male volunteers

    doi: 10.3389/fphar.2025.1533548

    Figure Lengend Snippet: Bio-equivalence between the insulin lispro test and reference products.

    Article Snippet: The test (T) formulation was a mixed protamine zinc recombinant human insulin lispro injection (3 mL: 300U), provided by Tonghua Dongbao Pharmaceutical Co., Ltd. (lot number: 2L12020100052).

    Techniques:

    Mean (±SD) plasma concentration–time curves (profile of changes in the blood concentration over time) (A) and semi-logarithmic curves (B) of the test and reference products of insulin lispro 25.

    Journal: Frontiers in Pharmacology

    Article Title: Pharmacokinetics and pharmacodynamics of insulin lispro 25 versus the original preparation (Humalog ® 25) in Chinese healthy male volunteers

    doi: 10.3389/fphar.2025.1533548

    Figure Lengend Snippet: Mean (±SD) plasma concentration–time curves (profile of changes in the blood concentration over time) (A) and semi-logarithmic curves (B) of the test and reference products of insulin lispro 25.

    Article Snippet: The reference (R) formulation was a mixed protamine zinc recombinant human insulin lispro injection (Humalog ® 25, 3 mL: 300U), manufactured by Eli Lilly Italia S.p.A (lot number: D183499).

    Techniques: Clinical Proteomics, Concentration Assay

    Mean (±SD) glucose infusion rate versus time of insulin lispro 25 (both test and reference products).

    Journal: Frontiers in Pharmacology

    Article Title: Pharmacokinetics and pharmacodynamics of insulin lispro 25 versus the original preparation (Humalog ® 25) in Chinese healthy male volunteers

    doi: 10.3389/fphar.2025.1533548

    Figure Lengend Snippet: Mean (±SD) glucose infusion rate versus time of insulin lispro 25 (both test and reference products).

    Article Snippet: The reference (R) formulation was a mixed protamine zinc recombinant human insulin lispro injection (Humalog ® 25, 3 mL: 300U), manufactured by Eli Lilly Italia S.p.A (lot number: D183499).

    Techniques:

    Bio-equivalence between the insulin  lispro  test and reference products.

    Journal: Frontiers in Pharmacology

    Article Title: Pharmacokinetics and pharmacodynamics of insulin lispro 25 versus the original preparation (Humalog ® 25) in Chinese healthy male volunteers

    doi: 10.3389/fphar.2025.1533548

    Figure Lengend Snippet: Bio-equivalence between the insulin lispro test and reference products.

    Article Snippet: The reference (R) formulation was a mixed protamine zinc recombinant human insulin lispro injection (Humalog ® 25, 3 mL: 300U), manufactured by Eli Lilly Italia S.p.A (lot number: D183499).

    Techniques:

    UV-Vis absorption response curves of AuNPs/GO (prepared with reducing agent 1.8 mL) to pure insulin solutions at different concentrations (18–30 μM).

    Journal: PLOS ONE

    Article Title: Differential insulin response characteristics of graphene oxide–gold nanoparticle composites under varied synthesis conditions

    doi: 10.1371/journal.pone.0317126

    Figure Lengend Snippet: UV-Vis absorption response curves of AuNPs/GO (prepared with reducing agent 1.8 mL) to pure insulin solutions at different concentrations (18–30 μM).

    Article Snippet: NovoRapid ® (Insulin Aspart Injection), Novolin ® R (Human Insulin Injection), Novolin ® N (Isophane Protamine Human Insulin Injection), Levemir ® (Insulin Detemir Injection), and Novolin ® 30R (Mixed Protamine Human Insulin Injection (30R)) were all purchased from Novo Nordisk Pharma (China) Co., Ltd.

    Techniques:

    ( a ) Visible absorption peak wavelength–concentration-response curves to insulin by AuNPs/GO prepared with different doses of the reducing agent. ( b ) Visible absorption peak shift–concentration-response curve of AuNPs/GO prepared with 2.0 mL of reducing agent.

    Journal: PLOS ONE

    Article Title: Differential insulin response characteristics of graphene oxide–gold nanoparticle composites under varied synthesis conditions

    doi: 10.1371/journal.pone.0317126

    Figure Lengend Snippet: ( a ) Visible absorption peak wavelength–concentration-response curves to insulin by AuNPs/GO prepared with different doses of the reducing agent. ( b ) Visible absorption peak shift–concentration-response curve of AuNPs/GO prepared with 2.0 mL of reducing agent.

    Article Snippet: NovoRapid ® (Insulin Aspart Injection), Novolin ® R (Human Insulin Injection), Novolin ® N (Isophane Protamine Human Insulin Injection), Levemir ® (Insulin Detemir Injection), and Novolin ® 30R (Mixed Protamine Human Insulin Injection (30R)) were all purchased from Novo Nordisk Pharma (China) Co., Ltd.

    Techniques: Concentration Assay

    Visible absorption peak shift–concentration-response curves of AuNPs/GO prepared with 2 mL reducing agent for different concentrations and types of commercial insulin.

    Journal: PLOS ONE

    Article Title: Differential insulin response characteristics of graphene oxide–gold nanoparticle composites under varied synthesis conditions

    doi: 10.1371/journal.pone.0317126

    Figure Lengend Snippet: Visible absorption peak shift–concentration-response curves of AuNPs/GO prepared with 2 mL reducing agent for different concentrations and types of commercial insulin.

    Article Snippet: NovoRapid ® (Insulin Aspart Injection), Novolin ® R (Human Insulin Injection), Novolin ® N (Isophane Protamine Human Insulin Injection), Levemir ® (Insulin Detemir Injection), and Novolin ® 30R (Mixed Protamine Human Insulin Injection (30R)) were all purchased from Novo Nordisk Pharma (China) Co., Ltd.

    Techniques: Concentration Assay

    Composition, characteristics, and limits of detection (LOD, 3SD/slope) by AuNPs/GO (prepared with 2 mL of reducing agent) for representative commercial insulin samples in this study.

    Journal: PLOS ONE

    Article Title: Differential insulin response characteristics of graphene oxide–gold nanoparticle composites under varied synthesis conditions

    doi: 10.1371/journal.pone.0317126

    Figure Lengend Snippet: Composition, characteristics, and limits of detection (LOD, 3SD/slope) by AuNPs/GO (prepared with 2 mL of reducing agent) for representative commercial insulin samples in this study.

    Article Snippet: NovoRapid ® (Insulin Aspart Injection), Novolin ® R (Human Insulin Injection), Novolin ® N (Isophane Protamine Human Insulin Injection), Levemir ® (Insulin Detemir Injection), and Novolin ® 30R (Mixed Protamine Human Insulin Injection (30R)) were all purchased from Novo Nordisk Pharma (China) Co., Ltd.

    Techniques:

    ( a ) Photograph of AuNPs/GO mixed with different concentrations of Novolin ® N. ( b ) Visible absorption peak shift–concentration-response curves for different concentrations of Novolin ® N using AuNPs/GO prepared with 2 and 2.3 mL of reducing agents, respectively. ( c ) Concentration testing result of the Levemir ® solution at ‘unknown concentration’ using AuNPs/GO compared with its actual concentration.

    Journal: PLOS ONE

    Article Title: Differential insulin response characteristics of graphene oxide–gold nanoparticle composites under varied synthesis conditions

    doi: 10.1371/journal.pone.0317126

    Figure Lengend Snippet: ( a ) Photograph of AuNPs/GO mixed with different concentrations of Novolin ® N. ( b ) Visible absorption peak shift–concentration-response curves for different concentrations of Novolin ® N using AuNPs/GO prepared with 2 and 2.3 mL of reducing agents, respectively. ( c ) Concentration testing result of the Levemir ® solution at ‘unknown concentration’ using AuNPs/GO compared with its actual concentration.

    Article Snippet: NovoRapid ® (Insulin Aspart Injection), Novolin ® R (Human Insulin Injection), Novolin ® N (Isophane Protamine Human Insulin Injection), Levemir ® (Insulin Detemir Injection), and Novolin ® 30R (Mixed Protamine Human Insulin Injection (30R)) were all purchased from Novo Nordisk Pharma (China) Co., Ltd.

    Techniques: Concentration Assay